Dexcom only hit profitability in 2019 it was only a lazy $20bn market cap!
RSH is a growth stock as it rolls out is device and drives SaaS users this is what is more important.
Don’t buy RSH for a stable dividend yield in the short term. Buy RSH for strong capital growth IMO DYOR.
Ann: Placement investor presentation, page-4
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.54M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 800000 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 363500 | 3 |
View Market Depth
| Last trade - 15.00pm 11/09/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable